Innate immune defense against community associated methicillin-resistant S.aureus
针对社区相关耐甲氧西林金黄色葡萄球菌的先天免疫防御
基本信息
- 批准号:8730944
- 负责人:
- 金额:$ 35.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-07-01 至 2015-02-28
- 项目状态:已结题
- 来源:
- 关键词:AffectAntibiotic TherapyAntibioticsApoptosisApoptoticBacteriaBindingBiologyCD47 geneCell DeathCellsCessation of lifeChloride IonChloridesClinicalClinical DataCommunitiesCytolysisCytoplasmic GranulesDataDiseaseDistantEatingEnvironmentEquus caballusEventExhibitsExperimental ModelsExtensive NecrosisFailureGenus staphylococcusGoalsHomeostasisHost DefenseHumanImmuneImmune systemIndividualInfectionInflammationInflammatory ResponseIngestionInvadedLungMediatingMembraneMembrane ProteinsMethicillin ResistanceMicrobeMolecularMorbidity - disease rateMusNADPH OxidaseNecrosisNeoplasm MetastasisOccupationsOrganismOxidantsPatientsPeroxidasesPhagocytesPhagocytosisPhagosomesPhenotypePneumoniaProteinsRecruitment ActivityRegulationRegulatory PathwayRelapseResolutionSignal PathwaySiteSkinStaphylococcal InfectionsStaphylococcus aureusSystemTestingTissuesToxinUp-RegulationVirulentWorkantimicrobial drugbasechlorinationcommunity livingcytokineinnovationinsightkillingsmacrophagemethicillin resistant Staphylococcus aureusmicrobialmicrobicidemicroorganismmortalityneutrophilnew therapeutic targetnovelprogramspublic health relevanceresponseskin disordertherapeutic target
项目摘要
DESCRIPTION (provided by applicant): This competitive renewal application will test three novel hypotheses about the interactions between human polymorphonuclear leukocytes (PMN) and ingested Staphylococcus aureus (SA) and their implications for the fate of human PMN, SA infection and inflammation. A significant fraction of ingested SA survives in PMN and prompts PMN to initiate cell fate programs that result in atypical apoptosis. These apoptotic, SA-laden PMN bind to macrophages (Mf), skew Mf cytokine profiles, and block efferocytosis, by incompletely defined mechanisms. SA-laden PMN not internalized by Mf undergo necrotic cell death and lysis, thereby releasing viable SA that are more virulent after passage through PMN. Within the framework of our novel, integrated view of microbicidal events in PMN, we will determine the transcriptional responses of SA that mediate their survival in PMN, define signaling pathways initiated by PMN in response to viable intracellular SA that trigger the atypical and eventual necrotic cell death seen in SA-infected PMN. Lastly, we will determine the mechanistic basis for and consequences of the failure of Mf to clear PMN-SA and the skewed cytokine profile of Mf that ingest PMN in which viable SA persist. The latter studies will provide important insight into how SA undermine cellular events that normally culminate in resolution of inflammation and return to tissue homeostasis. Each of the inter-related but independent aims is supported by strong preliminary data. Aim 1 Determine the mechanisms and consequences of survival of SA in human PMN phagosomes We will determine how SA upregulation of msrA1/B, YjiE, and other transcriptional responses to HOCl and other PMN- generated toxins promote SA survival (1.A.i-iii) and the functional consequences to PMN and Mf (1.B.). Aim 2 Determine mechanisms for functional changes in PMN and Mf during SA infection We will identify the signalling pathways and determine the molecular basis for "atypical" apoptosis of PMN-SA (2.A.) -- focusing on Mcl-1 (2.A.i), IL-1b (2.A.ii), and HIF-1a (2.A.iii) -- the decreased efferocytosis of PMN-SA by Mf and its impact on promoting inflammation (2.B), and the eventual necrotic cell death of PMN-SA (2.C). Our studies will identify mechanisms responsible for the atypical apoptosis and necrotic death of PMN, thereby providing novel insights into fundamental aspects of phagocyte control of the inflammatory response. From the microbial perspective, we will identify the functional consequences of transcriptional adaptations of surviving SA that were induced by PMN exposure, thus providing insight into SA vulnerability that could be exploited as novel targets for therapeutic attack.
描述(由申请人提供):本竞争性更新申请将测试关于人多形核白细胞(PMN)和摄入的金黄色葡萄球菌(SA)之间相互作用及其对人PMN、SA感染和炎症结局的影响的三种新假设。摄入的SA的一个显着的分数在PMN中存活,并提示PMN启动导致非典型凋亡的细胞命运程序。这些凋亡的SA负载的PMN通过不完全定义的机制结合巨噬细胞(Mf),使Mf细胞因子谱偏斜,并阻断巨噬细胞增多。未被Mf内化的载有SA的PMN经历坏死性细胞死亡和溶解,从而释放出在通过PMN后更具毒性的活SA。在我们的新的框架内,在PMN中的杀微生物事件的综合观点,我们将确定SA的转录反应,介导他们的生存在PMN中,定义由PMN启动的信号通路,在响应于激活的细胞内SA,触发非典型的和最终的坏死性细胞死亡看到SA感染的PMN。最后,我们将确定Mf未能清除PMN-SA的机制基础和后果,以及Mf摄取其中存活SA持续存在的PMN的偏斜细胞因子谱。后者的研究将提供重要的洞察SA如何破坏细胞事件,通常最终在炎症的解决和恢复组织稳态。每一个相互关联但又相互独立的目标都得到了强有力的初步数据的支持。目的1确定SA在人PMN吞噬体中存活的机制和结果我们将确定SA上调msrA 1/B、YjiE和其它对HOCl和其它PMN产生的毒素的转录应答如何促进SA存活(1.A.i-iii)以及对PMN和Mf的功能结果(1.B.)。目的2确定SA感染过程中PMN和Mf功能变化的机制我们将确定信号通路并确定PMN-SA“非典型”凋亡的分子基础(2.A.)--关注Mcl-1(2.A.i)、IL-1b(2.A.ii)和HIF-1a(2.A.iii)--Mf降低PMN-SA的胞浆细胞增多作用及其对促进炎症的影响(2.B),以及PMN-SA最终的坏死细胞死亡(2.C)。我们的研究将确定机制负责非典型凋亡和坏死性死亡的中性粒细胞,从而提供新的见解吞噬细胞控制炎症反应的基本方面。从微生物的角度来看,我们将确定由PMN暴露诱导的存活SA的转录适应的功能后果,从而提供对SA脆弱性的深入了解,可以利用作为治疗攻击的新靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William M. Nauseef其他文献
Neutrophil dysfunction in the pathogenesis of cystic fibrosis
中性粒细胞功能障碍在囊性纤维化发病机制中的作用
- DOI:
10.1182/blood.2021014699 - 发表时间:
2022-04-28 - 期刊:
- 影响因子:23.100
- 作者:
Guoshun Wang;William M. Nauseef - 通讯作者:
William M. Nauseef
Insights into myeloperoxidase biosynthesis from its inherited deficiency
- DOI:
10.1007/s001090050265 - 发表时间:
1998-08-26 - 期刊:
- 影响因子:4.200
- 作者:
William M. Nauseef - 通讯作者:
William M. Nauseef
755: Neutrophil Stimulation with Mycobacterium Bovis Bacillus Calmette-Guérin (BCG) Results in the Upregulation of Surface-Bound and Soluble Functional TRAIL/APO-2L
- DOI:
10.1016/s0022-5347(18)34924-3 - 发表时间:
2005-04-01 - 期刊:
- 影响因子:
- 作者:
Thomas S. Griffith;Troy J. Kemp;Aaron T. Ludwig;James K. Earel;Jill M. Moore;Bonita Moses;William M. Nauseef - 通讯作者:
William M. Nauseef
Immunochemical and Electrophoretic Analyses of Phosphorylated Native and Recombinant Neutrophil Oxidase Component p47-<em>Phox</em>
- DOI:
10.1182/blood.v76.12.2622.2622 - 发表时间:
1990-12-15 - 期刊:
- 影响因子:
- 作者:
William M. Nauseef;Bryan D. Volpp;Robert A. Clark - 通讯作者:
Robert A. Clark
William M. Nauseef的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William M. Nauseef', 18)}}的其他基金
Determinants of human neutrophil fate after phagocytosis
吞噬作用后人类中性粒细胞命运的决定因素
- 批准号:
10092904 - 财政年份:2018
- 资助金额:
$ 35.49万 - 项目类别:
Determinants of human neutrophil fate after phagocytosis
吞噬作用后人类中性粒细胞命运的决定因素
- 批准号:
10328225 - 财政年份:2018
- 资助金额:
$ 35.49万 - 项目类别:
Consequences of interactions between human neutrophils and Staphylococcus aureus
人类中性粒细胞和金黄色葡萄球菌之间相互作用的后果
- 批准号:
9131612 - 财政年份:2015
- 资助金额:
$ 35.49万 - 项目类别:
Consequences of interactions between human neutrophils and Staphylococcus aureus
人类中性粒细胞和金黄色葡萄球菌之间相互作用的后果
- 批准号:
9230328 - 财政年份:2015
- 资助金额:
$ 35.49万 - 项目类别:
Early airway innate immune responses to F. tularensis
对土拉弗朗西斯菌的早期气道先天免疫反应
- 批准号:
8305636 - 财政年份:2011
- 资助金额:
$ 35.49万 - 项目类别:
Early airway innate immune responses to F. tularensis
对土拉弗朗西斯菌的早期气道先天免疫反应
- 批准号:
7920676 - 财政年份:2010
- 资助金额:
$ 35.49万 - 项目类别:
Human neutrophils, phospholipase A2 and S.aureus: microbial targets and responses
人中性粒细胞、磷脂酶 A2 和金黄色葡萄球菌:微生物靶标和反应
- 批准号:
8195608 - 财政年份:2009
- 资助金额:
$ 35.49万 - 项目类别:
Human neutrophils, phospholipase A2 and S.aureus: microbial targets and responses
人中性粒细胞、磷脂酶 A2 和金黄色葡萄球菌:微生物靶标和反应
- 批准号:
7791569 - 财政年份:2009
- 资助金额:
$ 35.49万 - 项目类别:
相似海外基金
SBIR Phase II: Development of a urine dipstick test that can guide immediate and appropriate antibiotic therapy for treatment of complicated urinary tract infections
SBIR II 期:开发尿液试纸测试,可以指导复杂尿路感染的立即和适当的抗生素治疗
- 批准号:
2213034 - 财政年份:2023
- 资助金额:
$ 35.49万 - 项目类别:
Cooperative Agreement
Personalized Antibiotic Therapy in the Emergency Department: PANTHER Trial
急诊科的个性化抗生素治疗:PANTHER 试验
- 批准号:
10645528 - 财政年份:2023
- 资助金额:
$ 35.49万 - 项目类别:
Strategies for improving the efficacy of combinatorial antibiotic therapy in chronic infections
提高慢性感染联合抗生素治疗疗效的策略
- 批准号:
10736285 - 财政年份:2023
- 资助金额:
$ 35.49万 - 项目类别:
A Novel Bone Targeted Antibiotic Therapy for the Treatment of Infected Fractures
一种治疗感染性骨折的新型骨靶向抗生素疗法
- 批准号:
10603486 - 财政年份:2023
- 资助金额:
$ 35.49万 - 项目类别:
Severe Cutaneous Adverse Reactions Following Outpatient Antibiotic Therapy: A Population-based Study
门诊抗生素治疗后的严重皮肤不良反应:一项基于人群的研究
- 批准号:
449379 - 财政年份:2020
- 资助金额:
$ 35.49万 - 项目类别:
Studentship Programs
Sex-Specific Differences in End-of-Life Burdensome Interventions and Antibiotic Therapy in Nursing Home Residents With Advanced Dementia
患有晚期痴呆症的疗养院居民的临终干预和抗生素治疗的性别差异
- 批准号:
422034 - 财政年份:2020
- 资助金额:
$ 35.49万 - 项目类别:
Optimizing outpatient parenteral antibiotic therapy to support hospital-in-the-home program across the unique environmental conditions of Australia
优化门诊肠外抗生素治疗,以支持澳大利亚独特环境条件下的家庭医院计划
- 批准号:
nhmrc : 1197866 - 财政年份:2020
- 资助金额:
$ 35.49万 - 项目类别:
Investigator Grants
Resistance evolution in the presence of combination antibiotic therapy
联合抗生素治疗下耐药性的演变
- 批准号:
2241853 - 财政年份:2019
- 资助金额:
$ 35.49万 - 项目类别:
Studentship
Host-pathogen interactions in antibiotic therapy for listeriosis
李斯特菌病抗生素治疗中宿主与病原体的相互作用
- 批准号:
18K07106 - 财政年份:2018
- 资助金额:
$ 35.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Multipurpose targeted nano-antibiotic therapy to fight tough infection in bones
多用途靶向纳米抗生素疗法可对抗骨骼中的严重感染
- 批准号:
9788269 - 财政年份:2018
- 资助金额:
$ 35.49万 - 项目类别: